Itron, Inc. (NASDAQ:ITRI – Get Free Report) SVP Donald Reeves III sold 5,419 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total value of $539,407.26. Following the sale, the senior vice president owned 33,140 shares in the company, valued at $3,298,755.60. The trade was a 14.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Itron Price Performance
Shares of NASDAQ ITRI traded down $1.84 during trading on Monday, reaching $97.70. The company had a trading volume of 522,620 shares, compared to its average volume of 759,610. Itron, Inc. has a 52 week low of $88.57 and a 52 week high of $142.00. The stock has a market cap of $4.39 billion, a PE ratio of 15.01, a PEG ratio of 0.86 and a beta of 1.48. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.56 and a current ratio of 1.80. The business’s 50 day moving average price is $97.72 and its 200-day moving average price is $109.93.
Itron (NASDAQ:ITRI – Get Free Report) last released its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, beating the consensus estimate of $2.19 by $0.27. The business had revenue of $571.66 million for the quarter, compared to analysts’ expectations of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. Itron’s revenue was down 6.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.35 earnings per share. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Analysts expect that Itron, Inc. will post 5.33 earnings per share for the current year.
Institutional Trading of Itron
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on ITRI. Wall Street Zen downgraded Itron from a “buy” rating to a “hold” rating in a research report on Wednesday, January 14th. Zacks Research cut Itron from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. Weiss Ratings downgraded shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Guggenheim set a $155.00 price target on shares of Itron in a research report on Friday, February 13th. Finally, Argus reissued a “hold” rating on shares of Itron in a research note on Tuesday, November 4th. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $137.90.
Read Our Latest Report on ITRI
About Itron
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Read More
- Five stocks we like better than Itron
- The gold chart Wall Street is terrified of…
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
